Vitamin D: An Anti-Inflammatory Treatment Option for Depression?

REFERENCES

• Adler, A. J., & Vella, A. T. (2013). Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation. Oncoimmunology, 2, e22837. doi: 10.4161/onci.22837
   PubMed Web of Science ®Google Scholar
• Adler, U. C., Marques, A. H., & Calil, H. M. (2008). Inflammatory aspects of depression. Inflammation & Allergy Drug Targets, 7, 19–23.
   PubMedGoogle Scholar
• Akn, F., Ayca, B., Köse, N., Celik, O., Ylmaz, Y, Akn., M. N., Arnc, H., Ozkok, S. A., Covic, A., & Kanbay, M. (2013). Serum vitamin D and C-reactive protein levels are independently associated with diastolic dysfunction. Journal of Investigative Medicine, Oct 11 [Epub ahead of print]
   Web of Science ®Google Scholar
• Al-Harbi, K. S. (2012). Treatment-resistant depression: Therapeutic trends, challenges, and future directions. Patient Preference and Adherence, 6, 369–388.
   PubMed Web of Science ®Google Scholar
• Almeras, L., Eyles, D., Benech, P., Laffite, D., Villard, C., Pataitian, A., Boucraut, J., Mackay-Sim, A. (2007). Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders. Proteomics, 7, 769–780.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author.
   Google Scholar
• Baeten, D. L., & Kuchroo, V. K. (2013). How cytokine networks fuel inflammation: Interleukin-17 and a tale of two autoimmune diseases. Natural Medicine, 19, 824–825. doi: 10.1038/nm.3268
   PubMed Web of Science ®Google Scholar
• Basson, A. (2013). Vitamin D and Crohn's disease in the adult patient: A review. Journal of Parental Enteral Nutrition. Oct 23. [Epub ahead of print]
   Google Scholar
• Biancuzzo, R. M., Clarke, N., Reitz, R. E., Travison, T. G., & Holick, M. F. (2013).Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation. Journal of Clinical Endocrinology and Metabolism, 98, 973–979.
   PubMed Web of Science ®Google Scholar
• Daly, R. M., Gagnon, C., Lu, Z. X., Magliano, D. J., Dunstan, D. W., Sikaris, K. A., Zimmer, P. Z., Ebeling, P. R. (2012). Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: A national, population-based study. Clinical Endocrinology, 77, 26–35.
   PubMed Web of Science ®Google Scholar
• Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., & Reim, E. K. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67, 446–457.
   PubMed Web of Science ®Google Scholar
• Duivis, H. E., de Jonge, P., Penninx, B. W., Na, B. Y., Cohen, B. E., & Whooley, M. A. (2011). Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the Heart and Soul Study. American Journal of Psychiatry, 168, 913–920.
   PubMed Web of Science ®Google Scholar
• Duivis, H. E., Vogelzangs, N., Kupper, N., de Jonge, P., & Penninx, B. W., (2013). Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: Findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology, 38, 1573–1585.
   PubMed Web of Science ®Google Scholar
• Duivis, H. E., Kupper, N., Penninx, B. W., Na, B., de Jonge, P., & Wholley, M. A. (2013). Depressive symptoms and white blood cell count in coronary heart disease patients: Prospective findings from the Heart and Soul Study. Psychoneuroendocrinology, 38, 479–487.
   PubMed Web of Science ®Google Scholar
• Eyles, D., Almeras, L., Benech, P., Patatian, A., Mackay-Sim, A., McGrath, J., & Féron, F. (2007). Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. Journal of Steroid Biochemistry Molecular Biology, 103, 538–545.
   PubMed Web of Science ®Google Scholar
• Eyles, D. W., Burne, T. H., & McGrath, J. J. (2013). Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology, 34, 47–64.
   PubMed Web of Science ®Google Scholar
• Fornaro, M., Rocchi, G., Escelsior, A., Contini, P., & Martino, M. (2013). Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds? Journal of Affective Disorders, 145, 300–307.
   PubMed Web of Science ®Google Scholar
• Gartlehner, G., Hansen, R. A., Morgan, L. C. (2011). Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review. Rockville, MD: Agency for Healthcare Research and Quality. AHRQ Publication No. 12-EHC012-EF.
   Google Scholar
• Hiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012). Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: A meta-analysis. Psychological Medicine, 42, 2015–2026.
   PubMed Web of Science ®Google Scholar
• Holick, M. F. (2006). Resurrection of vitamin D deficiency and rickets, Journal of Clinical Investigations, 116, 2062–2072.
   PubMed Web of Science ®Google Scholar
• Holick, M. F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357, 266–281.
   PubMed Web of Science ®Google Scholar
• Holick, M. F. (2008). Vitamin D: A D-Lightful health perspective. Nutrition Reviews, 66, S182–S194.
   PubMed Web of Science ®Google Scholar
• Holick, M. F. (2009). Vitamin D status: Measurement, interpretation, and clinical application. Annals of Epidemiology, 19, 73–78.
   PubMed Web of Science ®Google Scholar
• Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2012). Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. Journal of Clinical Endocrinology and Metabolism, 11, 1153–1158. doi: 10.1210/jc.2011-2601.
   Web of Science ®Google Scholar
• Jaddou, H. Y., Batieha, A. M., Khader, Y. S., Kanaan, S. H., El-Khateeb, M. S. (2012). Depression is associated with low levels of 25-hydroxyvitamin D among Jordanian adults: Results from a national population survey. European Archives of Psychiatric and Clinical Neuroscience, 262, 321–327.
   PubMed Web of Science ®Google Scholar
• Jeffery, L. E., Burke, F., Mura, M., Zheng, Y., Qureshi, O. S., Hewison, M., Walker, L. S. (2009). 1,25-dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. Journal of Immunology, 183, 5458–5467.
   PubMed Web of Science ®Google Scholar
• Jones, G. (2008). Pharmacokinetics of vitamin D toxicity. American Journal of Clinical Nutrition, 88, 582S–586S.
   PubMed Web of Science ®Google Scholar
• Kallaur, A. P., Kaimen-Maciel, D. R., Morimoto, H. K., Watanabee, M.A., Georgeto, S. M., & Reiche, E. M. (2011). Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (review). International Journal of Molecular Medicine, 28, 467–479.
   PubMed Web of Science ®Google Scholar
• Kongsbak, M., Levring, T. B., Geisler, C., & von Essen, M. R. (2013). The vitamin d receptor and T cell function. Frontiers in Immunology, 4, 148. doi: 10.3389/fimmu.2013.00148
   PubMed Web of Science ®Google Scholar
• Lee, D. M., Tajar, A., O'Neill, T. W., O'Connor, D. B., Bartfai, G. (2011). Lower vitamin D levels are associated with depression among community-dwelling European men. Journal of Psychpharmacology, 25, 1320–1328.
   PubMed Web of Science ®Google Scholar
• Licona-Limón, P., Kim, L. K., Palm, N. W., & Flavell, R. A. (2013). TH2, allergy and group 2 innate lymphoid cells. Nature Immunology, 14, 536–542.
   PubMed Web of Science ®Google Scholar
• Long, K. Y., & Nguyen, L. T. (2013). Roles of vitamin D in amyotrophic lateral sclerosis: Possible genetic and cellular signaling mechanisms. Molecular Brain, 16. doi: 10.1186/1756-6606-6-16
   Google Scholar
• Liu, Y., Ho, R. C., & Mak, A. (2012). Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression. Journal of Affective Disorders, 139, 230–239.
   PubMed Web of Science ®Google Scholar
• Loprinzi, P. D., Herod, S. M., Cardinal, B. J., & Noakes, T. D. (2013). Physical activity and the brain: A review of this dynamic, bi-directional relationship. Brain Research, 1539, 95–104.
   Google Scholar
• Lotrich, F. E., El-Gabalawy, H., Guenther, L. C., & Ware, C. F. (2011). The role of inflammation in the pathophysiology of depression: Different treatments and their effects. Journal of Rheumatology, 88(Suppl), 48–54.
   Google Scholar
• Maes, M., Berk, M., Goehler, L., Song, C., Anderson, G., Galecki, P. (2012). Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Medicine, 10, 66.
   PubMed Web of Science ®Google Scholar
• Maes, M., Leonard, B. E., Myint, A. M., Kubera, M., & Verkerk, R. (2011). The new “5-HT” hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Progress in Neuropsychopharmacology & Biological Psychiatry, 35, 702–721.
   PubMed Web of Science ®Google Scholar
• Masi, G., & Brovedani, P. (2011). The hippocampus, neurotrophic factors and depression, CNS. Drugs, 25, 913–931.
   PubMed Web of Science ®Google Scholar
• May, H. T., Bair, T. L., Lappe, D. L., Anderson, J. L., Home, B. D., Carlquist, J. E., & Muhlestein, J. B. (2010). Association of vitamin D levels with incident depression among a general cardiovascular population. American Heart Journal, 169, 1037–1043.
   Web of Science ®Google Scholar
• Milaneschi, Y., Hoogendijk, W., Lips, P., Heijboer, A. C., Schoevers, R., van Hemert, A. M., Beekman, A. T. (2013). The association between low vitamin D and depressive disorders. Molecular Psychiatry, Apr 9. doi: 10.1038/mp.2013.36 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Miller, A. H., Maletic, V., & Raison, C. L. (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65, 732–741.
   PubMed Web of Science ®Google Scholar
• Miller, A. H., Haroon, E., Raison, C. L., & Felger, J.C. (2013). Cytokine targets in the brain: Impact on neurotransmitters and neurocircuits. Depression and Anxiety, 30, 297–306.
   PubMed Web of Science ®Google Scholar
• Mora-Ripoll, R. (2010). The therapeutic value of laughter in medicine. Alternative Therapies in Health and Medicine, 16, 56–64.
   PubMed Web of Science ®Google Scholar
• Müller, N., & Schwartz, M. J. (2010). Immune system and schizophrenia. Current Immunology Reviews, 6, 213–220.
   PubMedGoogle Scholar
• National Research Council. (2011). Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press.
   Google Scholar
• Neupane, S. P., Lien, L., Hilberg, T., & Bramness, J. C. (2013). Vitamin D deficiency in alcohol-use disorders and its relationship to comorbid major depression: A cross-sectional study of inpatients in Nepal. Drug and Alcohol Dependence, 133, 480–485.
   PubMed Web of Science ®Google Scholar
• Paykel, E. S., Scott, J., Cornwall, P. L., Abbott, R., Crane, C., Pope, M., & Johnson, A. L. (2005). Duration of relapse prevention after cognitive therapy in residual depression: Follow-up of controlled trial. Psychological Medicine, 35, 59–68.
   PubMed Web of Science ®Google Scholar
• Pierrot-Deseilligny, C., Rivaud-Pèchoux, S., Clerson, P., de Paz, R., & Souberbidle, J. C. (2012). Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Therapeutic Advances in Neurological Disorders, 5, 187–198.
   PubMed Web of Science ®Google Scholar
• Piet, J., & Hougaard, E. (2011). The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: A systematic review and meta-analysis. Clinical Psychology Review, 31, 1032–1340.
   PubMed Web of Science ®Google Scholar
• Płudowski, P., Karczmarewicz, E., Bayer, M., Carter, G., Chlebna-Sokół, D. (2013). Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe—recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynologia Polska, 64, 319–327.
   PubMed Web of Science ®Google Scholar
• Powell, N. D., Tarr, A. J., & Sheridan, J. F. (2013). Psychosocial stress and inflammation in cancer. Brain and Behavior Immunology, 30(Suppl), S41–S47.
   PubMed Web of Science ®Google Scholar
• Powe, C. E., Evans, M. K., Wender, J., Zonderman, A. B., Berg, A. H., Nalls, M., Tamez, H., (2013). Vitamin D–binding protein and vitamin D status of black Americans and white Americans. New England Journal of Medicine. 369, 991–2000.
   PubMed Web of Science ®Google Scholar
• Querishi, N. A., & Al-Bedah, A. M. (2013). Mood disorders and complementary and alternative medicine: A literature review. Neuropsychiatric Disease and Treatment, 9, 639–658.
   PubMed Web of Science ®Google Scholar
• Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J. (2010). CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: Relationship to CNS immune responses and depression. Molecular Psychiatry, 15, 393–403.
   PubMed Web of Science ®Google Scholar
• Raison, C. L., & Miller, A. H. (2013). Do cytokines really sing the blues? Cerebrum, 10. [Published online]
   Google Scholar
• Ramsberg, J., Asseburg, C., & Henricksson, M. (2012). Effectiveness and cost-effectiveness of antidepressants in primary care: A multiple treatment comparison meta-analysis and cost-effectiveness model. PLoS One, 7, e42003. doi: 10.1371/journal.pone.0042003
   PubMed Web of Science ®Google Scholar
• Rosenkranz, M. A., Davidson, R. J., Maccoon, D. G., Sheridan, J. F., Kalin, N. H., & Lutz, A. (2013). A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation. Brain and Behavior Immunology, 27, 174–184.
   PubMed Web of Science ®Google Scholar
• Ross, C. A., Taylor, C. L., Yaktime, A. L., & Del Valle, H. B. (2010). Dietary reference intakes for calcium and vitamin. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Institute of Medicine. Washington, DC: National Academies Press.
   Google Scholar
• Sakthisway, R., & Raymond, A. A. (2013). The clinical significance of vitamin D in systemic lupus erythematosus: A systematic review. PLoS One, 8, e55275. doi: 10.1371/journal.pone.0055275
   Web of Science ®Google Scholar
• Shaffer, J. A., Edmondson, D., Chaplin, W. F., Schwartz, J. E., Shimbo, D., Burg, M. M., Rieckmann, N., & Davidson, K. W. (2011). Directionality of the relationship between depressive symptom dimensions and C-reactive protein in patients with acute coronary syndromes. Psychosomatic Medicine, 73, 370–377.
   Google Scholar
• Signorello, L. B., Shi, J., Cai, Q., Zheng, W., Williams, S. M., Long, J., Cohen, S. S. (2011). Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D Levels among African Americans. PLos One, 6, e28623. doi: 10.1371/journal.pone.0028623
   PubMed Web of Science ®Google Scholar
• Song, C., Halbreich, U., Han, C., Leonard, B. E., & Luo, H. (2009). Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: The effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry, 42, 182–188.
   PubMed Web of Science ®Google Scholar
• Stewart, J. C., Rand, K. L., Muldoon, M. F., & Kamarck, T. W. (2009). A prospective evaluation of the directionality of the depression-inflammation relationship. Brain, Behavior & Immunity, 23, 936–944.
   PubMed Web of Science ®Google Scholar
• Strangier, U., Hilling, C., Heidenreich, T., Risch, A. K., Barocka, A., Schlosser, R., Kronfeld, K., Ruckes, C. (2013). Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: A multicenter prospective randomized controlled trial. American Journal of Psychiatry, 170, 624–632.
   PubMed Web of Science ®Google Scholar
• Taylor, M. J., Godlewska, B., Near, J., Christmas, D., Pokokar, J., Collier, J., (2013). Effect of interferon-α on cortical glutamate in patients with hepatitis C: A proton magnetic resonance spectroscopy study. Psychological Medicine, 10(May), 1–7. [Epub ahead of print]
   Google Scholar
• Tourjman, V., Koussai, E., Koué, M. E., Rocchetti, M., Fortin-Fournier, S., Fusar-Poli, P., & Potvin, S. (2013). Antipsychotics’ effects on blood levels of cytokines in schizophrenia: A meta-analysis. Schizophrenia Research. doi: 10.1016/j.schres.2013.10.011 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• van Hess, M. L., Rotter, T., Ellermann, T., & Evers, S. M. (2013). The effectiveness of individual interpersonal psychotherapy as a treatment for major depressive disorder in adult outpatients: A systematic review. BMC Psychiatry, 13(11), 22–31. doi: 10.1186/1471-244X-13-22
   PubMed Web of Science ®Google Scholar
• Vanoirbeek, E., Krishnan, A., Eelen, G., Verlinden, L., Bouillon, R., Feldman, D., & Verstuyf, A. (2011). The anti-cancer and anti-inflammatory actions of 1,25(OH)2D3. Best practice & research. Clinical Endocrinology and Metabolism, 25, 593–604.
   Google Scholar
• Ward, M. P., & Irazoqui, P. P. (2010). Evolving refractory major depressive disorder diagnostic and treatment paradigms: Toward closed-loop therapeutics. Frontiers in Neuroengineering, 3, 7–21. doi: 10.3389/fneng.2010. 00007
   PubMedGoogle Scholar
• White, J. H. (2012). Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection. Archives of Biochemistry and Biophysics, 523, 58–63.
   PubMed Web of Science ®Google Scholar
• World Health Organization (2008). The global burden of disease: 2004 Update. Geneva, Switzerland: WHO Press.
   Google Scholar
• Wright, N. C., Chen, L., Niu, J., Neogi, T., Javiad, K., Nevitt, M. A., Lewis, C. E., & Curtis, J. R. (2012). Defining physiologically “normal” vitamin D in African Americans. Osteoporosis International, 23, 2283–2291.
   PubMed Web of Science ®Google Scholar
• Zu, S., Xiang, Y. T., Liu, J., Zhang, L., Wang, G., Ma, X., Kilbourne, A. M., Ungvari, G. S. (2013). A comparison of cognitive-behavioral therapy, antidepressants, their combination and standard treatment for Chinese patients with moderate-severe major depressive disorders. Journal of Affective Disorders. S0165-0327, (13), 00708-8. doi: 10.1016/j.jad.2013.09.022 [Epub ahead of print]
   Google Scholar